
Biotech firm leveraging collective expertise in molecular biology, regenerative medicine, and pharmaceuticals for innovation.
Amerstem, founded by a team of scientists from premier institutions like Johns Hopkins, Yale, and the University of Arizona, is a biotechnology company with a mission to innovate using their extensive expertise in molecular biology, regenerative medicine, and pharmaceuticals. The company has developed a sustainable and cost-effective cell culture core technology platform inspired by natural plant physiology and defense mechanisms. Their primary focus is on producing biologically active compounds, particularly Quillaja-derived saponin vaccine immunoadjuvants, to offer eco-friendly alternatives and preserve Quillaja saponaria trees.
Notable affiliations include professional experience at Johns Hopkins Hospital, Cedars-Sinai Medical Center, and Bayer Pharma. Amerstem has achieved significant milestones in creating a sustainable production method for phytoactives, contributing to both environmental conservation and medical advancements. Their innovative approach has positioned them as a key player in the biotech industry, providing critical solutions that blend scientific rigor with ecological responsibility.
Amerstem's most recent funding round was for $375k (USD) in March 2015.
As of Mar 6, 2015, Amerstem has disclosed funding of $375k (USD).

Chi Botanic
chibotanic.com

AVM Biotechnology
avmbiotech.com

Amyris
amyris.com

Stramsen Biotech

Qurgen
qurgen.com
Qwell Pharmaceuticals

American CryoStem

Avra

Phytomedics

APstem Therapeutics
apstemtx.com

Stemtech
stemtech.com

Amplifica
amplificabio.com

AgeX Therapeutics

Antria
antria.org
Innate Immunity

StemSave
stemsave.com

Immunis

42Bio
42bio.com
Regenemed
regenemed.com

ImStem Biotechnology
imstem.com